重编程T细胞代谢以增强采用细胞疗法
Meghan Kates1,2, Samuel D Saibil1,2
1Department of Medical Oncology and Haematology, Princess Margaret Cancer Center, University Health Network, 610 University Ave., Toronto, ON M5G 2M9, Canada.
International immunology
|February 16, 2024
概括
采用细胞疗法 (ACT) 对血液癌症有希望,但在固体瘤中扎. 在瘤微环境 (TME) 中增强T细胞代谢和线粒体功能是提高ACT疗效的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞的新陈代谢
- 癌症治疗 癌症治疗
背景情况:
- 采用细胞疗法 (ACT) 对血液性恶性瘤有效.
- 固体瘤由于免疫抑制和代谢要求的瘤微环境 (TME) 提出了挑战.
- T细胞代谢与T细胞功能和持久性密切相关.
研究的目的:
- 通过不同生命阶段审查T细胞代谢.
- 在TME中探索T细胞代谢和线粒体缺陷.
- 讨论通过向T细胞代谢来增强ACT疗效的策略.
主要方法:
- 关于T细胞代谢的当前文献的综述.
- 在TME的背景下分析T细胞代谢和线粒体功能.
- 讨论潜在的代谢途径操纵.
主要成果:
- 已建立的T细胞代谢模型为了解T细胞功能提供了一个框架.
- TME对注入的T细胞提出了重要的代谢和免疫抑制挑战.
- 代谢和线粒体路径可以调节以改善T细胞的持久性和功能.
结论:
- 了解T细胞代谢对于克服TME相关的治疗耐药性至关重要.
- 针对代谢途径提供了一个有希望的策略,以提高ACT在固体瘤中的有效性.
- 对T细胞代谢的进一步研究可以改善患者在ACT中的结果.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cell-mediated Immune Responses
68.3K
Overview
68.3K
T Cell Activation and Clonal Selection
732
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
732
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


